12.19
Tenax Therapeutics Inc (TENX) 最新ニュース
Tenax Therapeutics names Timothy Healey as chief commercial officer By Investing.com - Investing.com Australia
Invus affiliates disclose 2.1% stake in Tenax Therapeutics (TENX) - Stock Titan
Tenax brings in drug launch veteran Timothy Healey to prep TNX-103 - Stock Titan
Tenax Therapeutics, Inc. Appoints Timothy Healey as Chief Commercial Officer, Effective May 4, 2026 - marketscreener.com
Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Tenax Therapeutics appoints Thomas Staab as chief financial officer - MSN
Tenax wins bullish view at Cantor ahead of pivotal readout - MSN
Tenax Therapeutics (NASDAQ:TENX) Is In A Good Position To Deliver On Growth Plans - Sahm
Discipline and Rules-Based Execution in TENX Response - Stock Traders Daily
How do interest rates affect Tenax Therapeutics (TENX) stock | Q4 2025: Profit Exceeds ViewsSpin Off - Newser
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics names new CFO - MSN
Tenax Therapeutics names Thomas Staab as chief financial officer By Investing.com - Investing.com India
Tenax Therapeutics (TENX) Stock Movers | Q4 2025: EPS Tops ViewsStock Analysis Community - UBND thành phố Hải Phòng
Companies Like Tenax Therapeutics (NASDAQ:TENX) Are In A Position To Invest In Growth - Yahoo Finance
Tenax Therapeutics Names New CFO to Support Growth - TipRanks
Tenax Therapeutics names Thomas Staab as chief financial officer - Investing.com
[ARS] TENAX THERAPEUTICS, INC. SEC Filing - Stock Titan
Tenax Therapeutics (NASDAQ: TENX) 2026 proxy details director slate, auditor vote - Stock Titan
Tenax Therapeutics (NASDAQ: TENX) hires new CFO Thomas Staab with equity grants - Stock Titan
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer - The Manila Times
Tenax Therapeutics, Inc. Announces Chief Financial Officer Changes - marketscreener.com
TENX SEC FilingsTenax Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Tenax Therapeutics (TENX) Stock Index Trade (Ticks Lower) 2026-04-20Retail Flow - Cổng thông tin điện tử Tỉnh Sơn La
Behavioral Patterns of TENX and Institutional Flows - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Panic Selling: Is Tenax Therapeutics Inc forming a double bottom2026 Institutional & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Is Tenax Therapeutics (TENX) Stock Priced Correctly | Price at $14.27, Down 1.11%Wall Street Picks - Newser
CEO Moves: Is Tenax Therapeutics Inc forming a double bottom2026 Market Overview & Short-Term Trading Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX) and Ligand Pharma (LGND) - The Globe and Mail
If You Invested $1,000 in Tenax Therapeutics Inc (TENX) - Stock Titan
TENX Options Volatility — NASDAQ:TENX - TradingView
TENX Options Chain — NASDAQ:TENX - TradingView
TENAX Therapeutics (NASDAQ: TENX) — Morgan Stanley reports 3.5%/3.4% positions - Stock Titan
[SCHEDULE 13G/A] TENAX THERAPEUTICS, INC. Amended Passive Investment Disclosure - Stock Titan
Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Is Tenax Therapeutics (TENX) Stock Suitable for 2026 | Price at $14.59, Down 1.95%Correlation Analysis - Cổng thông tin điện tử tỉnh Lào Cai
(TENX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TENX Should I Buy - Intellectia AI
[EFFECT] TENAX THERAPEUTICS, INC. SEC Filing - Stock Titan
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Volume Summary: What are Tenax Therapeutics Incs recent SEC filings showingOil Prices & Daily Stock Trend Watchlist - baoquankhu1.vn
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
How (TENX) Movements Inform Risk Allocation Models - Stock Traders Daily
Tenax Therapeutics may offer up to $300 million of securities - marketscreener.com
Tenax Therapeutics May Offer Up To $300 Million Of Securities - TradingView — Track All Markets
Tenax Therapeutics (NASDAQ: TENX) registers $300M shelf to sell securities - Stock Titan
大文字化:
|
ボリューム (24 時間):